Precision BioSciences
DTIL
77 hedge funds and large institutions have $23M invested in Precision BioSciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 15 closing their positions.
150% more call options, than puts
Call options by funds: $5K | Put options by funds: $2K
0.17% less ownership
Funds ownership: 1.45% → 1.28% (-0.17%)
10% less funds holding
Funds holding: 86 → 77 (-9)
37% less capital invested
Capital invested by funds: $36.5M → $23M (-$13.5M)
38% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 26
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$800K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$322K |
| 3 |
Renaissance Technologies
New York
|
+$145K |
| 4 |
Two Sigma Investments
New York
|
+$57.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.53M |
| 2 |
CA
CHI Advisors
New York
|
-$1.42M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$480K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$282K |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$215K |
DTIL Hedge Fund Activity: Q2 2023 in Review
77 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2023, worth a combined $23M — down 37% from $36.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of DTIL and 6 opened new positions — a net loss of 9 holders — while 26 trimmed existing stakes and 16 added.
The largest buyer was Stifel Financial, adding an estimated $800K. The largest seller was Millennium Management, cutting an estimated $1.53M.
- 77 institutional investors held Precision BioSciences (DTIL) as of Q2 2023, down from 86 in Q1 2023.
- Funds reported $23M of Precision BioSciences stock for Q2 2023, down 37% quarter-over-quarter.
- 6 funds opened new Precision BioSciences positions in Q2 2023 and 15 closed out, a net change of -9 holders.
- The largest Precision BioSciences buyer in Q2 2023 was Stifel Financial, an estimated $800K added.
- The largest Precision BioSciences seller in Q2 2023 was Millennium Management, an estimated $1.53M sold.
Based on aggregated 13F filings for Q2 2023.